Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma

R Popat; H Oakervee; C Williams; Mark Cook; Charles Craddock; S Basu; C Singer; S Harding; N Foot; S Hallam; L Odeh; S Joel; J Cavenagh

doi:10.1111/j.1365-2141.2008.07572.x

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma

R Popat, H Oakervee, C Williams, Mark Cook, Charles Craddock, S Basu, C Singer, S Harding, N Foot, S Hallam, L Odeh, S Joel, J Cavenagh

Research output: Contribution to conference (unpublished) › Paper

42 Citations (Scopus)

Original language	English
Pages	887-894
Number of pages	8
DOIs	https://doi.org/10.1111/j.1365-2141.2008.07572.x
Publication status	Published - 1 Mar 2009
Event	Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark - Duration: 1 Mar 2009 → …

Conference

Conference	Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark
Period	1/03/09 → …

Keywords

dexamethasone
melphalan
multiple myeloma
bortezomib
relapsed

Access to Document

10.1111/j.1365-2141.2008.07572.x

Cite this

Popat, R., Oakervee, H., Williams, C., Cook, M., Craddock, C., Basu, S., Singer, C., Harding, S., Foot, N., Hallam, S., Odeh, L., Joel, S., & Cavenagh, J. (2009). Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. 887-894. Paper presented at Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark. https://doi.org/10.1111/j.1365-2141.2008.07572.x

@conference{7865d32488d345d4815b853a17aa1451,

title = "Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma",

keywords = "dexamethasone, melphalan, multiple myeloma, bortezomib, relapsed",

author = "R Popat and H Oakervee and C Williams and Mark Cook and Charles Craddock and S Basu and C Singer and S Harding and N Foot and S Hallam and L Odeh and S Joel and J Cavenagh",

year = "2009",

month = mar,

day = "1",

doi = "10.1111/j.1365-2141.2008.07572.x",

language = "English",

pages = "887--894",

note = "Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark ; Conference date: 01-03-2009",

}

Popat, R, Oakervee, H, Williams, C, Cook, M, Craddock, C, Basu, S, Singer, C, Harding, S, Foot, N, Hallam, S, Odeh, L, Joel, S & Cavenagh, J 2009, 'Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma', Paper presented at Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark, 1/03/09 pp. 887-894. https://doi.org/10.1111/j.1365-2141.2008.07572.x

TY - CONF

T1 - Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma

AU - Popat, R

AU - Oakervee, H

AU - Williams, C

AU - Cook, Mark

AU - Craddock, Charles

AU - Basu, S

AU - Singer, C

AU - Harding, S

AU - Foot, N

AU - Hallam, S

AU - Odeh, L

AU - Joel, S

AU - Cavenagh, J

PY - 2009/3/1

Y1 - 2009/3/1

KW - dexamethasone

KW - melphalan

KW - multiple myeloma

KW - bortezomib

KW - relapsed

U2 - 10.1111/j.1365-2141.2008.07572.x

DO - 10.1111/j.1365-2141.2008.07572.x

M3 - Paper

C2 - 19183191

SP - 887

EP - 894

T2 - Annual Meeting of the European-Hematology-Association, 2008. Copenhagen, Denmark

Y2 - 1 March 2009

ER -